Track the 서흥 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 서흥 has recorded 1 insider filings. Market capitalisation: €230bn. The latest transaction was filed on 9 April 2026 (Sale). Among the most active insiders: 우승환. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
서흥 is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in the manufacturing of pharmaceutical products and medical devices.